Movement Disorders Publications
NYU Langone’s Kellar Family Division of Movement Disorders faculty publish frequently in prestigious, peer-reviewed journals. Here is a selection of their recent publications.
Treatment of Periodic Alternating Nystagmus as a Consequence of Ataxia-Telangiectasia
Journal of neuro-ophthalmology. 2024 Mar 01; 44:e151-e152
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Lancet. Neurology. 2024 Mar ; 23:243-255
Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings
Neurology neuroimmunology & neuroinflammation. 2024 Mar ; 11:e200194
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial
Nature medicine. 2024 Feb ; 30:606
Poor Accuracy of Manually Derived Head Computed Tomography Parameters in Predicting Intracranial Hypertension After Nontraumatic Intracranial Hemorrhage
Neurocritical care. 2023 Dec ; 39:677-689
Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia
Movement disorders. 2023 Oct ; 38:1850-1860
Sodium Oxybate in Alcohol-Responsive Essential Tremor of Voice: An Open-Label Phase II Study
Movement disorders. 2023 Oct ; 38:1936-1944
Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophy
Parkinsonism & related disorders. 2023 Oct ; 115:105821